Provexis plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PXS.L research report →
Companywww.provexis.com
Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats.
- CEO
- Ian Ford
- IPO
- 2004
- Employees
- 2
- HQ
- Reading, GB
Price Chart
Valuation
- Market Cap
- $22.29M
- P/E
- -36.91
- P/S
- 25.58
- P/B
- 19.47
- EV/EBITDA
- -35.67
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 49.24%
- Op Margin
- -103.94%
- Net Margin
- -69.30%
- ROE
- -49.45%
- ROIC
- -146.70%
Growth & Income
- Revenue
- $1.29M · 61.13%
- Net Income
- $-452,720 · 22.78%
- EPS
- $-0.00 · 33.33%
- Op Income
- $-448,319
- FCF YoY
- -76.97%
Performance & Tape
- 52W High
- $1.55
- 52W Low
- $0.01
- 50D MA
- $1.02
- 200D MA
- $0.84
- Beta
- 0.66
- Avg Volume
- 2.21M
Get TickerSpark's AI analysis on PXS.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PXS.L Coverage
We haven't published any research on PXS.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PXS.L Report →